News | Artificial Intelligence | March 23, 2020

Vantage Galan 3T the First System in the MR Portfolio with Access to Advanced intelligent Clear-IQ Engine (AiCE)

Advanced intelligent Clear-IQ Engine (AiCE) is pending 510(k) clearance on the Aquilion ONE / PRISM Edition and Aquilion Prime SP CT systems, as well as the Vantage Galan 3T and Vantage Orian 1.5T MR systems

March 23, 2020 — Canon Medical Systems USA, Inc. has received 510(k) clearance on its Advanced intelligent Clear-IQ Engine (AiCE) for the Vantage Galan 3T magnetic resonance imaging (MR) system, further expanding access to its new Deep Learning Reconstruction (DLR) technology. This technology, which is also available across a majority of Canon Medical’s CT product portfolio, uses a deep learning algorithm to differentiate true MR signal from noise so that it can suppress noise while enhancing signal, forging a new frontier for MR image reconstruction.

AiCE was trained using vast amounts of high-quality image data, and features a deep learning neural network that can reduce noise and boost signal to quickly deliver sharp, clear and distinct images, further opening doors for advancements in MR imaging. Capabilities include:

  • High quality images: AiCE allows for the differentiation of true signal from noise through deep learning innovation to match the spatial resolution and low-noise properties of advanced scanning and reconstruction, while maintaining the true structure of the anatomy.
  • Seamless integration into routine practice: AiCE is the world’s first fully integrated deep learning reconstruction for MR, and is built directly into the scan protocols for seamless workflow.
  • Preferred AiCE MR image quality over non-AI reconstruction images: Following a blinded image comparison of AiCE DLR reconstructed images with images reconstructed with conventional methods without AiCE, physicians stated preference for AiCE images for clarity and resolution.

“AiCE utilizes a next generation approach to MR image reconstruction, further proving Canon Medical’s leadership and commitment to innovation in diagnostic imaging,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc. “With the expansion of this unique DLR method across modalities and into MR, we’re elevating diagnostic imaging capabilities for our customers by bringing the power of AI to routine imaging to provide more possibilities in improving patient care than ever before.”

For more information: www.us.medical.canon


Related Content

News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | X-Ray

July 14, 2026 — A team of crew members aboard a commercial spaceflight acquired the first diagnostic X-rays during an ...

Time July 14, 2026
arrow
News | PACS

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
Subscribe Now